Follow on Google News News By Tag * Market Forecast * Revenues * Unmet Need * Drivers * Barriers * Pharma * Clinical Trials * Marketed Products * Pipeline * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | New Market Report: Stomach Cancer - Pipeline Assessment and Market Forecasts to 2017New Pharmaceuticals research report from GlobalData is now available from Fast Market Research
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts. GlobalData's analysis suggests that the global gastric cancer market was worth $750m in 2009. It is forecast to grow at a Compound Annual Growth Rate (CAGR) of 8.3% to $1,422m in 2017. Most of the chemotherapies are already off-patent while Taxotere and Xeloda are expected to lose their patents during 2010 to 2011. Taxotere's generic version, produced by Hospira, has already been approved in Europe through the decentralized procedure. The market is expected to be driven by the increase in demand due to the launch of promising targeted therapies currently in the late stage of development. The pending approval of Herceptin in the US and Japan will also boost the revenues generated in the stomach cancer market. However, the new therapies are not expected go off-patent before 2017. Therefore, the market is expected to witness strong growth in market revenues in the forecast period. Scope The scope of the report includes: * Annualized global stomach cancer market revenues data from 2001 to 2009, forecast for eight years to 2017. * Geographies covered in this report include the United States (US), the United Kingdom (UK), Italy, Spain, Germany, France and Japan. * Pipeline analysis data split across different phases by mechanism of action and emerging trends. The key classes of mechanism of action are mTOR inhibitors, PARP inhibitors, microtubule inhibitors, VEGFR inhibitors, multiple tyrosine kinase inhibitors, Heat Shock Protein 90 inhibitors, Eg5 inhibitors, Farnesyl-OH- * Analysis of the current and future competition in the global stomach cancer market. The key market players covered include GlaxoSmithKline, Novartis Pharmaceuticals, Merck & Co, Eli Lilly and Company, Amgen, Hoffmann-La Roche and Pfizer Inc. * Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. * Key topics covered include a strategic competitor assessment, market characterization, unmet needs and the implications for the future stomach cancer market Reasons to buy The report will enhance your decision making capability. It will allow you to: * Develop and design your in-licensing and out-licensing strategies through a review of the pipeline products and technologies and by identifying the companies with the most promising product candidates in the pipeline. * Develop business strategies by understanding the trends shaping and driving the global stomach cancer market. * Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global stomach cancer market in future. * Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. * Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage. * Organize your sales and marketing efforts by identifying the market categories and segments that present the maximum opportunities for consolidation, investments and strategic partnerships. * What's the next big thing in the global stomach cancer market landscape? - Identify, understand and capitalize. For more information or to purchase this report, go to: - http://www.fastmr.com/ Partial Table of Contents: 1 Table of contents 3 1.1 List of Tables 5 1.2 List of Figures 5 2 Stomach Cancer Introduction 6 2.1 GlobalData Pipeline Report Guidance 7 3 Stomach Cancer: Market Characterization 8 3.1 Overview 8 3.2 Stomach Cancer Market Size 8 3.3 Stomach Cancer Market Forecast and CAGR 10 3.4 Drivers and Barriers for the Stomach Cancer Market 11 3.4.1 Drivers for the Stomach Cancer Market 11 3.4.2 Barriers for the Stomach Cancer Market 11 3.5 Opportunity and Unmet Need 11 3.6 Key Takeaway 13 4 Stomach Cancer Market: Competitive Assessment 14 4.1 Overview 14 4.2 Strategic Competitor Assessment 14 4.3 Product Profiles of Major Marketed Drugs in the Stomach Cancer Market 15 4.3.1 Herceptin (trastuzumab) 4.3.2 Taxotere (docetaxel) 17 4.3.3 Xeloda 18 4.3.4 Gleevec (imatinib) 19 4.4 Key Takeaway 21 5 Stomach Cancer Market: Pipeline Assessment 22 5.1 Overview 22 5.2 Strategic Pipeline Assessment 23 5.2.1 Technology Trends Analytic Framework 23 5.3 Stomach Cancer - Promising Drugs Under Clinical Development 25 5.4 Molecule Profile for Promising Drugs Under Clinical Development 26 5.4.1 Tykerb (Lapatinib) 26 5.4.2 Afinitor (Everolimus) 5.4.3 IMC-1121B (ramucirumab) 5.4.4 Cetuximab plus capecitabine and cisplatin 28 5.4.5 Apatinib (YN968DI) 28 5.5 Stomach Cancer Market - Clinical Pipeline by Mechanism of Action 29 5.6 Stomach Cancer Market - Pipeline by Clinical Phase of Development 30 5.6.1 Stomach Cancer Market - Phase III Clinical Pipeline 31 5.6.2 Stomach Cancer Market - Phase II Clinical Pipeline 33 5.6.3 Stomach Cancer Market - Phase I Clinical Pipeline 44 5.6.4 Stomach Cancer Market - Pre-Clinical Pipeline 47 5.6.5 Stomach Cancer Market Filed Molecules Pipeline 47 5.7 Key Takeaway 47 6 Stomach Cancer: Implications for Future Market Competition 48 Full Table of Contents is available at: -- http://www.fastmr.com/ About GlobalData GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||
Account Phone Number